NUTEX HEALTH INC (NUTX) Stock Analyst Earnings Estimates
NASDAQ:NUTX - Nasdaq - US67079U3068 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 219.294M 1,066.83% | 247.646M 12.93% | 479.949M 93.80% | 795.83M 65.82% | 835.48M 4.98% | |
| EBITDA YoY % growth | 8.553M 203.00% | 16.3M 90.58% | 156.677M 861.21% | 282.67M 80.42% | 306.6M 8.47% | |
| EBIT YoY % growth | -4.578M 49.23% | -1.292M 71.78% | 137.705M 10,758.31% | 89.814M -34.78% | 145.56M 62.07% | |
| Operating Margin | -2.09% | -0.52% | 28.69% | 11.29% | 17.42% | |
| EPS YoY % growth | N/A | -4.50 95.61% | 8.73 294.00% | 7.93 -9.22% | 13.79 74.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.62 -2,209.57% | 2.04 218.60% | 4.86 -56.34% | 5.83 127.91% |
| Revenue Q2Q % growth | 190.42M 150.28% | 190.14M 141.31% | 199.3M -22.64% | 210.83M -0.45% |
| EBITDA Q2Q % growth | 60.028M 190.14% | 59.803M 151.49% | 67.162M -49.57% | 77.622M 0.42% |
| EBIT Q2Q % growth | 30.198M 152.28% | 57.702M 471.99% | 85.611M -25.03% | 100.98M 39.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 2.56 526.67% | 2.34 | 0.22 | 9.60% |
| Q4 2024 Q2Q % growth | 11.12 | -0.13 | 11.25 | 8,939.67% |
| Q3 2024 Q2Q % growth | -1.72 -14.67% | -0.24 | -1.48 | -602.61% |
| Q2 2024 Q2Q % growth | -0.07 95.33% | -0.30 | 0.23 | 76.34% |
| Q1 2024 Q2Q % growth | -0.60 60.00% | 0.00 | -0.60 | % |
| Q4 2023 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | % |
| Q3 2023 Q2Q % growth | -1.50 | -0.77 | -0.74 | -96.08% |
| Q2 2023 Q2Q % growth | -1.50 -4,900.00% | -0.77 | -0.74 | -96.08% |
| Q1 2023 Q2Q % growth | -1.50 | -2.30 | 0.79 | 34.64% |
| Q4 2022 Q2Q % growth | -3.00 | -2.30 | -0.71 | -30.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 211.789M 213.98% | 120.05M | 91.739M | 76.42% |
| Q4 2024 Q2Q % growth | 257.618M 269.77% | 82.748M | 174.87M | 211.33% |
| Q3 2024 Q2Q % growth | 78.795M 25.62% | 74.689M | 4.106M | 5.50% |
| Q2 2024 Q2Q % growth | 76.082M 29.12% | 69.564M | 6.518M | 9.37% |
| Q1 2024 Q2Q % growth | 67.454M 19.75% | 66.096M | 1.358M | 2.05% |
| Q4 2023 Q2Q % growth | 69.669M 29.68% | 72.828M | -3.159M | -4.34% |
| Q3 2023 Q2Q % growth | 62.723M 120.89% | 64.515M | -1.792M | -2.78% |
| Q2 2023 Q2Q % growth | 58.924M 1.51% | 63.291M | -4.367M | -6.90% |
| Q1 2023 Q2Q % growth | 56.329M -28.81% | 57.171M | -842K | -1.47% |
| Q4 2022 Q2Q % growth | 53.724M 807.50% | 50.924M | 2.8M | 5.50% |
| Q3 2022 Q2Q % growth | 28.395M 409.88% | % | ||
| Q2 2022 Q2Q % growth | 58.048M 997.11% | % | ||
| Q1 2022 Q2Q % growth | 79.127M 3,828.85% | % | ||
| Q4 2021 Q2Q % growth | 5.92M 1,410.20% | % | ||
| Q3 2021 Q2Q % growth | 5.569M 1,491.14% | % | ||
| Q2 2021 Q2Q % growth | 5.291M 1,296.04% | % | ||
| Q1 2021 Q2Q % growth | 2.014M 332.19% | % | ||
| Q4 2020 Q2Q % growth | 392K -70.90% | % | ||
| Q3 2020 Q2Q % growth | 350K 79.49% | % | ||
| Q2 2020 Q2Q % growth | 379K -14.83% | % | ||
| Q1 2020 Q2Q % growth | 466K 119.81% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -264.53% | -26.7% | 91.07% |
| Revenue | 0% | 84.37% | 0% | 90.06% |